GSK Reports Higher Third-Quarter Sales, Boosted by Specialty Medicines
GSK said third-quarter turnover was 8.89 billion pounds ($11.83 billion), with growth boosted by its specialty medicines segment.
Story updates
07:46:10 AM UTC
SquawkNews
The FTSE 100 company said turnover rose 4% at actual exchange rates and 5% at constant currencies to £8.89bn.Core operating profit increased 5% at constant currencies to £3.08bn, while core earnings per share edged up 1% to 54.6p, reflecting higher sales and a favourable product mix, partly offset…
By Adria CalatayudGSK reported an increase in third-quarter sales, boosted by its specialty medicines segment, as the U.K. drugmaker works to cut costs and speed up the development of its drug pipeline.The company said Wednesday that third-quarter turnover was 8.89 billion pounds ($11.83 billion…